04:53 PM EDT, 06/16/2025 (MT Newswires) -- Stephen F. Betz, Chief Scientific Officer, on June 12, 2025, sold 97,483 shares in Crinetics Pharmaceuticals ( CRNX ) for $3,141,877. Following the Form 4 filing with the SEC, Betz has control over a total of 99,713 common shares of the company, with 99,713 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1658247/000095017025086804/xslF345X05/ownership.xml